USFDA, Telangana DCA Discuss on Drug Inspections and GMP Standards
USFDA investigators delivered several technical sessions on advanced good manufacturing practices (GMP) concepts: Reports
HYDERABAD: The second regulatory forum between the United States Food and Drug Administration (USFDA) and the Drugs Control Administration (DCA), Telangana, discussed best regulatory practices and inspections at its meeting here on Tuesday.
USFDA officials Greg Smith, country director; Lisa Flores and Rafeeq Habeeb, regulatory specialists (pharmaceuticals); and Dhruv Shah, senior technical adviser attended the meeting.
A statement said the forum had served as a knowledge-sharing platform aimed at exchanging and learning best regulatory practices related to the inspection of medical products and the advancement of public health. USFDA investigators delivered several technical sessions on advanced good manufacturing practices (GMP) concepts.
DCA officers presented their recent initiatives, inspection approaches, and inspection trends, particularly with regard to revised Schedule M and sterile manufacturing facility inspections.